title: ES-8891, an orally active inhibitor of human renin.
abstract: A newly synthesized orally active renin inhibitor, N-morpholinoacetyl-(1-naphthyl)-L-alanyl-(4-thiazolyl)-L-alanyl (3S,4S)-4-amino-3-hydroxy-5-cyclohexylpentanoyl-n-hexylamide (ES-8891), was found to be a highly potent competitive inhibitor of human renin with an inhibition constant of 1.1 nM. This inhibitor was also active against monkey renin, although there was less inhibition of renin in pig, rabbit, and rat. ES-8891 did not inhibit cathepsin D, pepsin, trypsin, chymotrypsin, angiotensin converting enzyme, and urinary kallikrein at a concentration of 10(-5) M. A single oral administration of ES-8891 (10 or 30 mg/kg) to conscious, sodium-depleted marmosets caused a dose-related decrease in plasma renin activity and blood pressure. ES-8891 (30 mg/kg) produced an 80% inhibition of plasma renin activity, which lasted for more than 6 hours. Kidney renin messenger RNA was not significantly changed 6 hours after oral administration of ES-8891 (30 mg/kg). A single oral administration of 240 mg ES-8891 to healthy human volunteers (n = 6) produced a significant inhibition of plasma renin activity (75% inhibition at 0.5 and 1 hour, 50% inhibition at 2 hours) with a good correlation of plasma levels of ES-8891. There were no significant changes in blood pressure or heart rate, and no adverse effects were observed. These results suggest that ES-8891 is an orally active human renin inhibitor that may be clinically useful.
authors.affiliation: Department of Internal Medicine, Kinki Central Hospital, Itami, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Kokubu
authors.forename: K
authors.initials: K
authors.lastname: Hiwada
authors.forename: E
authors.initials: E
authors.lastname: Murakami
authors.forename: S
authors.initials: S
authors.lastname: Muneta
authors.forename: Y
authors.initials: Y
authors.lastname: Kitami
authors.forename: P F
authors.initials: PF
authors.lastname: Salmon
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000818:Animals; D002143:Callitrichinae; D055598:Chemical Phenomena; D002621:Chemistry; D004151:Dipeptides / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008297:Male; D009025:Morpholines / Q000494:pharmacology*; D012016:Reference Values; D012083:Renin / Q000097:blood; D000092502:Renin Inhibitors
chemical_list: D004151:Dipeptides; D009025:Morpholines; D012083:Renin; D000092502:Renin Inhibitors; C064483:ES 8891